Research
Metabolic adaptation
Prior GLP-1 agonist use is not associated with in-hospital mortality in critically ill patients.
Clinicians may consider that prior GLP-1 agonist use does not adversely affect mortality in critically ill patients.
StrongRefutesmedium confidence
The matched GLP-1 agonist and comparison groups showed similar in-hospital mortality (5.1% vs. 4.9%, odds ratio [OR]: 1.05, 95% confidence interval [CI]: 0.58 to 1.91, p = .88).
Why this rating
Based on a large cohort study design with propensity matching.
Source
Prior GLP‐1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity‐matched analysis
Albert K. Park et al. · Journal of Hospital Medicine · 2025
cohort · n=15191Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →